JPMorgan raised the firm’s price target on Sanofi (SNY) to EUR 105 from EUR 100 and keeps a Neutral rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- Sanofi price target lowered to EUR 85 from EUR 90 at Deutsche Bank
- AstraZeneca (AZN) Sees Its Cancer Drug Added to China’s Reimbursement List
- Sanofi (SNY) Is Seeking to Change How It Gives Discounts to Hospitals
- Sanofi planning changes to 340B hospital drug discount plan, WSJ reports
- Sanofi’s Sarclisa Nears EU Approval for Myeloma
Questions or Comments about the article? Write to editor@tipranks.com